Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron J Turtle

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
International Journal of Hematology|December 17, 2013
Chimeric antigen receptor modified T cell therapy for B cell malignanciesCameron J Turtle
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J Turtle
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2021
CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to SuccessSalvatore Fiorenza, Cameron J Turtle
Blood|December 12, 2024
High-dimensional data bridges for CARsSalvatore Fiorenza, Cameron J Turtle
Immunometabolism|February 8, 2021
Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell TransplantationSalvatore Fiorenza, Cameron J Turtle
Current Research in Translational Medicine|April 8, 2018
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapyJordan Gauthier, Cameron J Turtle
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Artificial antigen-presenting cells for use in adoptive immunotherapyCameron J Turtle, Stanley R Riddell
Immunotherapy|February 10, 2018
CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib eraKevin A Hay, Cameron J Turtle
Blood Advances|November 14, 2023
ICANS prophylaxis: potentially transformative but elusiveMark R Dowling, Cameron J Turtle
Expert Opinion on Biological Therapy|February 19, 2020
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapyCassie K Chou, Cameron J Turtle
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Hematology|December 17, 2013
Chimeric antigen receptor modified T cell therapy for B cell malignanciesCameron J Turtle
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J Turtle
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2021
CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to SuccessSalvatore Fiorenza, Cameron J Turtle
Blood|December 12, 2024
High-dimensional data bridges for CARsSalvatore Fiorenza, Cameron J Turtle
Immunometabolism|February 8, 2021
Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell TransplantationSalvatore Fiorenza, Cameron J Turtle
Current Research in Translational Medicine|April 8, 2018
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapyJordan Gauthier, Cameron J Turtle
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Artificial antigen-presenting cells for use in adoptive immunotherapyCameron J Turtle, Stanley R Riddell
Immunotherapy|February 10, 2018
CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib eraKevin A Hay, Cameron J Turtle
Blood Advances|November 14, 2023
ICANS prophylaxis: potentially transformative but elusiveMark R Dowling, Cameron J Turtle
Expert Opinion on Biological Therapy|February 19, 2020
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapyCassie K Chou, Cameron J Turtle
Pageof 13